Jack Allen Score: 35
Analyst at
Robert W. Baird
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
-16.2%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
63%
10 W / 6 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
0%
0 W / 13 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
44%
4 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
25%
2 W / 6 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
100%
8 W / 0 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Sep 03, 2026 |
Ultragenyx Pharmaceutical Inc.
RARE
|
SELL |
$16.00
Est. +40%
|
$26.53 | $12.73 (Low) |
Target Met
|
$17.16
+35.3%
|
| Jun 25, 2026 |
Faeth Therapeutics, Inc.
FTH
|
BUY |
$57.00
Est. +131%
|
$24.67 | $27.03 |
Pending
|
$19.99
-19.0%
|
| Apr 27, 2026 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$13.00
Est. +7%
|
$13.94 | $10.15 (Low) |
Target Met
|
$12.31
+11.7%
|
| Jan 27, 2026 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$7.00
Est. +51%
|
$14.40 | $10.15 (Low) |
Pending
|
$12.31
+14.5%
|
| Oct 30, 2025 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$9.00
Est. +31%
|
$13.12 | $7.95 (Low) |
Target Met
|
$12.31
+6.2%
|
| Oct 02, 2025 |
Taysha Gene Therapies Inc
TSHA
|
BUY |
$12.00
Est. +152%
|
$4.77 | $7.30 |
Miss
|
$4.36
-8.6%
|
| Nov 06, 2024 |
Arcellx Inc
ACLX
|
BUY |
$106.00
Est. +23%
|
$86.09 | $107.37 |
Precision Hit (±3%)
|
$115.07
+33.7%
|
| Oct 30, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
SELL |
$65.00
Est. +7%
|
$69.91 | $51.29 (Low) |
Target Met
|
$57.11
+18.3%
|
| Oct 24, 2024 |
Intellia Therapeutics Inc
NTLA
|
BUY |
$18.00
Est. +14%
|
$15.85 | $28.24 |
Target Met
|
$12.31
-22.3%
|
| Sep 25, 2024 |
Voyager Therapeutics Inc
VYGR
|
BUY |
$18.00
Est. +198%
|
$6.04 | $8.27 |
Miss
|
$1.87
-69.0%
|
| Sep 16, 2024 |
Instil Bio Inc
TIL
|
BUY |
$180.00
Est. +174%
|
$65.58 | $76.13 |
Miss
|
$6.99
-89.3%
|
| Jun 24, 2024 |
Intellia Therapeutics Inc
NTLA
|
SELL |
$24.00
Est. +8%
|
$26.00 | $5.90 (Low) |
Target Met
|
$12.31
+52.7%
|
| Jun 12, 2024 |
Mereo Biopharma Group Plc - ADR
MREO
|
BUY |
$8.00
Est. +109%
|
$3.83 | $5.02 |
Miss
|
$0.30
-92.1%
|
| May 17, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
SELL |
$72.00
Est. +6%
|
$76.97 | $52.93 (Low) |
Target Met
|
$57.11
+25.8%
|
| May 09, 2024 |
CRISPR Therapeutics AG
CRSP
|
SELL |
$52.00
Est. +2%
|
$53.29 | $30.04 (Low) |
Target Met
|
$51.78
+2.8%
|
| Jun 13, 2022 |
Allogene Therapeutics Inc
ALLO
|
BUY |
$11.00
Est. +13%
|
$9.74 | - | - |
$1.19
-87.8%
|
Ultragenyx Pharmaceutical Inc.
RARE
Sep 03, 2026
Signal & Target
SELL
$16.00
Start Price
$26.53
Best Price (1Y)
$12.73
Current Price
$17.16
Return
+35.3%
Faeth Therapeutics, Inc.
FTH
Jun 25, 2026
Signal & Target
BUY
$57.00
Start Price
$24.67
Best Price (1Y)
$27.03
Current Price
$19.99
Return
-19.0%
Intellia Therapeutics Inc
NTLA
Apr 27, 2026
Signal & Target
SELL
$13.00
Start Price
$13.94
Best Price (1Y)
$10.15
Current Price
$12.31
Return
+11.7%
Intellia Therapeutics Inc
NTLA
Jan 27, 2026
Signal & Target
SELL
$7.00
Start Price
$14.40
Best Price (1Y)
$10.15
Current Price
$12.31
Return
+14.5%
Intellia Therapeutics Inc
NTLA
Oct 30, 2025
Signal & Target
SELL
$9.00
Start Price
$13.12
Best Price (1Y)
$7.95
Current Price
$12.31
Return
+6.2%
Taysha Gene Therapies Inc
TSHA
Oct 02, 2025
Signal & Target
BUY
$12.00
Start Price
$4.77
Best Price (1Y)
$7.30
Current Price
$4.36
Return
-8.6%
Arcellx Inc
ACLX
Nov 06, 2024
Signal & Target
BUY
$106.00
Start Price
$86.09
Best Price (1Y)
$107.37
Current Price
$115.07
Return
+33.7%
Signal & Target
SELL
$65.00
Start Price
$69.91
Best Price (1Y)
$51.29
Current Price
$57.11
Return
+18.3%
Intellia Therapeutics Inc
NTLA
Oct 24, 2024
Signal & Target
BUY
$18.00
Start Price
$15.85
Best Price (1Y)
$28.24
Current Price
$12.31
Return
-22.3%
Voyager Therapeutics Inc
VYGR
Sep 25, 2024
Signal & Target
BUY
$18.00
Start Price
$6.04
Best Price (1Y)
$8.27
Current Price
$1.87
Return
-69.0%
Instil Bio Inc
TIL
Sep 16, 2024
Signal & Target
BUY
$180.00
Start Price
$65.58
Best Price (1Y)
$76.13
Current Price
$6.99
Return
-89.3%
Intellia Therapeutics Inc
NTLA
Jun 24, 2024
Signal & Target
SELL
$24.00
Start Price
$26.00
Best Price (1Y)
$5.90
Current Price
$12.31
Return
+52.7%
Mereo Biopharma Group Plc - ADR
MREO
Jun 12, 2024
Signal & Target
BUY
$8.00
Start Price
$3.83
Best Price (1Y)
$5.02
Current Price
$0.30
Return
-92.1%
Signal & Target
SELL
$72.00
Start Price
$76.97
Best Price (1Y)
$52.93
Current Price
$57.11
Return
+25.8%
CRISPR Therapeutics AG
CRSP
May 09, 2024
Signal & Target
SELL
$52.00
Start Price
$53.29
Best Price (1Y)
$30.04
Current Price
$51.78
Return
+2.8%
Allogene Therapeutics Inc
ALLO
Jun 13, 2022
Signal & Target
BUY
$11.00
Start Price
$9.74
Best Price (1Y)
-
Current Price
$1.19
Return
-87.8%